Revenue | ₹133.07Cr |
Net Profits | ₹15.17Cr |
Net Profit Margins | 11.40% |
Tatva Chintan Pharma Chem Ltd’s revenue jumped 54.84% since last year same period to ₹133.07Cr in the Q3 2025-2026. On a quarterly growth basis, Tatva Chintan Pharma Chem Ltd has generated 6.87% jump in its revenue since last 3-months.
Tatva Chintan Pharma Chem Ltd’s net profit jumped 10735.71% since last year same period to ₹15.17Cr in the Q3 2025-2026. On a quarterly growth basis, Tatva Chintan Pharma Chem Ltd has generated 52.92% jump in its net profits since last 3-months.
Tatva Chintan Pharma Chem Ltd’s net profit margin jumped 6897.98% since last year same period to 11.40% in the Q3 2025-2026. On a quarterly growth basis, Tatva Chintan Pharma Chem Ltd has generated 43.1% jumped in its net profit margins since last 3-months.
The revenue for Tatva Chintan Pharma Chem Ltd in the Q3 results 2025 was ₹133.07Cr.
The net profit for Tatva Chintan Pharma Chem Ltd in the Q3 results 2025 was ₹15.17Cr.
The net profit margin for Tatva Chintan Pharma Chem Ltd in the Q3 results 2025 was 11.40%.
The revenue for Tatva Chintan Pharma Chem Ltd in the Q3 results 2024 was ₹85.94Cr.
The net profit for Tatva Chintan Pharma Chem Ltd in the Q3 results 2024 was ₹0.14Cr.
The net profit margin for Tatva Chintan Pharma Chem Ltd in the Q3 results 2024 was 0.16%.